Investing Profile

Rajeev Dadoo

Photo of Rajeev Dadoo, Partner at SR One

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Stanford University Network
702 CONNECTIONS
cb
SR One Partner
9
CompanyStageDateRound SizeTotal Raised
Renalys Pharma
Series AJul 2024$39M
$39M
Nimbus Therapeutics
Private EquitySep 2023$210M
$640M
Co-investors: Krishna Yeshwant (GV (Google Ventures)), Bruce Booth (Atlas Venture), Vicki Sato (ARCH Venture Partners), Peter Kolchinsky (RA Capital), Nikola Trbovic (Pfizer Venture Investments)
Dren Bio
Series BJun 2022$65M
Series AOct 2020$60M
$130M
Co-investors: Andrew Schiff (Aisling Capital), Chandra Leo (HBM Partners AG)
ARS Pharmaceuticals
Series DAug 2021$55M
$55M
Co-investors: Peter Kolchinsky (RA Capital)
Tranquis Therapeutics
Series AJul 2020$30M
$30M
Co-investors: Taro Inaba (Remiges Ventures), Edgar Engleman (Vivo Capital)
iPierian
Series UnknownSep 2013$30M
Series BNov 2010$29M
$83M
Co-investors: Krishna Yeshwant (GV (Google Ventures)), Jim Scopa (MPM Capital), Beth Seidenberg (Kleiner Perkins), Wesley Chan (FPV Fund), Martin Alexander Gershon (Endeavor Venture Funds)
IlluminOss Medical
Series CSep 2012$28M
$28M
Partner SR One2004 - Present
Knox College BA
Stanford University PhD
The Wharton School/Univ. Penn MBA